Company / PP&E (Net)
Savara Inc PP&E (Net) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$165.0K
FY2024
5-year range
$51.0K / $270.0K
FY2020-FY2024
Trend
-38.9%
vs FY2023
Sector context
#181 of 193
Health Care
What the data says
Among 193 Health Care companies, Savara Inc is in the bottom 6% for pp&e (net). PP&E (Net) has fluctuated over the past 10 years, ranging from $51,000 in FY2022 to $925,000 in FY2017.
Based on SEC 10-K filings.
$165,000 in FY2024 with a 5-year CAGR of -14.1%.
Improved from $51,000 to $165,000 over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +31.2%
- 5-Year CAGR
- -14.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 193This company $165.0K Sector average $777.6M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.1%, indicating a declining trend.
- In FY2024, pp&e (net) decreased 38.9% year-over-year.
- Ranks #181 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $165.0K | -38.9% |
| FY2023 | $270.0K | +429.4% |
| FY2022 | $51.0K | -30.1% |
| FY2021 | $73.0K | -53.2% |
| FY2020 | $156.0K | -55.7% |
| FY2019 | $352.0K | -32.6% |
| FY2018 | $522.0K | -43.6% |
| FY2017 | $925.0K | +16.6% |
| FY2016 | $793.0K | +250.9% |
| FY2015 | $226.0K | +20.2% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026